AE11345
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
1mg | 96% | in stock | $42.00 | $30.00 | - + | |
2mg | 96% | in stock | $77.00 | $54.00 | - + | |
5mg | 96% | in stock | $130.00 | $91.00 | - + | |
10mg | 96% | in stock | $157.00 | $110.00 | - + | |
25mg | 96% | in stock | $235.00 | $165.00 | - + | |
50mg | 96% | in stock | $401.00 | $281.00 | - + | |
100mg | 96% | in stock | $681.00 | $477.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AE11345 |
Chemical Name: | TAK-733 |
CAS Number: | 1035555-63-5 |
Molecular Formula: | C17H15F2IN4O4 |
Molecular Weight: | 504.2267 |
MDL Number: | MFCD24386349 |
SMILES: | OC[C@@H](Cn1cnc2c(c1=O)c(Nc1ccc(cc1F)I)c(c(=O)n2C)F)O |
TAK-733, also known as TAK-632, is a potent and selective inhibitor of the mitogen-activated protein kinase kinase (MEK) enzyme. MEK is a critical component of the MAPK signaling pathway, which regulates cell growth, proliferation, and survival. In chemical synthesis, TAK-733 plays a crucial role as a tool compound for studying the MAPK pathway and its implications in various cellular processes.TAK-733 is commonly used in the research and development of potential cancer therapies due to its ability to inhibit MEK activity, leading to the suppression of downstream signaling pathways involved in tumor progression. By blocking MEK, TAK-733 helps to disrupt abnormal cell growth and promote cancer cell death, making it a valuable asset in the pursuit of novel anti-cancer agents.Furthermore, TAK-733's specificity towards MEK makes it a preferential choice in chemical synthesis aimed at understanding the intricate signaling mechanisms involved in cellular behavior. Its precise targeting of the MAPK pathway allows researchers to investigate the cascades of reactions triggered by MEK inhibition, offering insights into potential therapeutic strategies for various diseases beyond cancer.Through its application in chemical synthesis, TAK-733 serves as a powerful tool for unraveling the complexities of cellular signaling pathways and offers a promising avenue for advancing drug discovery efforts targeted towards MEK-related disorders.